These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20625992)

  • 1. Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays.
    Malinowsky K; Wolff C; Ergin B; Berg D; Becker KF
    J Cell Physiol; 2010 Nov; 225(2):364-70. PubMed ID: 20625992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR.
    Berg D; Wolff C; Malinowsky K; Tran K; Walch A; Bronger H; Schuster T; Höfler H; Becker KF
    J Cell Physiol; 2012 Jan; 227(1):204-12. PubMed ID: 21391216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis.
    Becker KF; Schott C; Hipp S; Metzger V; Porschewski P; Beck R; Nährig J; Becker I; Höfler H
    J Pathol; 2007 Feb; 211(3):370-8. PubMed ID: 17133373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues.
    Malinowsky K; Wolff C; Gündisch S; Berg D; Becker K
    J Cancer; 2010 Dec; 2():26-35. PubMed ID: 21197262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of formalin-fixed and paraffin-embedded tissues for diagnosis and therapy in routine clinical settings.
    Berg D; Malinowsky K; Reischauer B; Wolff C; Becker KF
    Methods Mol Biol; 2011; 785():109-22. PubMed ID: 21901596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of signalling pathways in formalin-fixed and paraffin-embedded cancer tissues.
    Berg D; Hipp S; Malinowsky K; Böllner C; Becker KF
    Eur J Cancer; 2010 Jan; 46(1):47-55. PubMed ID: 19914823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
    VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF
    Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue.
    Shi Y; Huang W; Tan Y; Jin X; Dua R; Penuel E; Mukherjee A; Sperinde J; Pannu H; Chenna A; DeFazio-Eli L; Pidaparthi S; Badal Y; Wallweber G; Chen L; Williams S; Tahir H; Larson J; Goodman L; Whitcomb J; Petropoulos C; Winslow J
    Diagn Mol Pathol; 2009 Mar; 18(1):11-21. PubMed ID: 19214113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
    Wulfkuhle JD; Edmiston KH; Liotta LA; Petricoin EF
    Nat Clin Pract Oncol; 2006 May; 3(5):256-68. PubMed ID: 16683004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.
    Speer R; Wulfkuhle J; Espina V; Aurajo R; Edmiston KH; Liotta LA; Petricoin EF
    Cancer Genomics Proteomics; 2007; 4(3):157-64. PubMed ID: 17878519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
    Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
    Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse phase protein microarrays for theranostics and patient-tailored therapy.
    Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF
    Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
    Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protein microarrays and personalized medicine].
    Yu X; Schneiderhan-Marra N; Joos TO
    Ann Biol Clin (Paris); 2011; 69(1):17-29. PubMed ID: 21463992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A novel fixed paraffin-embedded tissue processing for proteomic analysis].
    Bellet V; Rochaix P; Mange A; Solassol J
    Ann Biol Clin (Paris); 2008; 66(4):401-7. PubMed ID: 18725341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization.
    Henke RT; Eun Kim S; Maitra A; Paik S; Wellstein A
    Methods; 2006 Apr; 38(4):253-62. PubMed ID: 16513366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of signalling pathways by reverse phase protein arrays.
    Malinowsky K; Wolff C; Schott C; Becker KF
    Methods Mol Biol; 2013; 1049():285-99. PubMed ID: 23913224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse phase protein arrays: mapping the path towards personalized medicine.
    Gallagher RI; Espina V
    Mol Diagn Ther; 2014 Dec; 18(6):619-30. PubMed ID: 25358623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.